Skip to main content
Full access
New Research
Published Online: 1 June 2014

Adult Diagnostic and Functional Outcomes of DSM-5 Disruptive Mood Dysregulation Disorder

Abstract

Objective

Disruptive mood dysregulation disorder (DMDD) is a new disorder for DSM-5 that is uncommon and frequently co-occurs with other psychiatric disorders. Here, the authors test whether meeting diagnostic criteria for this disorder in childhood predicts adult diagnostic and functional outcomes.

Method

In a prospective, population-based study, individuals were assessed with structured interviews up to six times in childhood and adolescence (ages 10 to 16 years; 5,336 observations of 1,420 youths) for symptoms of DMDD and three times in young adulthood (ages 19, 21, and 24–26 years; 3,215 observations of 1,273 young adults) for psychiatric and functional outcomes (health, risky/illegal behavior, financial/educational functioning, and social functioning).

Results

Young adults with a history of childhood DMDD had elevated rates of anxiety and depression and were more likely to meet criteria for more than one adult disorder relative to comparison subjects with no history of childhood psychiatric disorders (noncases) or individuals meeting criteria for psychiatric disorders other than DMDD in childhood or adolescence (psychiatric comparison subjects). Participants with a history of DMDD were more likely to have adverse health outcomes, be impoverished, have reported police contact, and have low educational attainment as adults compared with either psychiatric or noncase comparison subjects.

Conclusions

The long-term prognosis of children with DMDD is one of pervasive impaired functioning that in many cases is worse than that of other childhood psychiatric disorders.

Formats available

You can view the full content in the following formats:

Supplementary Material

Supplementary Material (668_ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 668 - 674
PubMed: 24781389

History

Received: 14 September 2013
Revision received: 25 November 2013
Accepted: 16 January 2014
Published online: 1 June 2014
Published in print: June 2014

Authors

Affiliations

William E. Copeland, Ph.D.
From the Center for Developmental Epidemiology, Duke University Medical Center, Durham, N.C.; the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; and the University of North Carolina at Chapel Hill.
Lilly Shanahan, Ph.D.
From the Center for Developmental Epidemiology, Duke University Medical Center, Durham, N.C.; the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; and the University of North Carolina at Chapel Hill.
Helen Egger, M.D.
From the Center for Developmental Epidemiology, Duke University Medical Center, Durham, N.C.; the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; and the University of North Carolina at Chapel Hill.
Adrian Angold, M.R.C.Psych.
From the Center for Developmental Epidemiology, Duke University Medical Center, Durham, N.C.; the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; and the University of North Carolina at Chapel Hill.
E. Jane Costello, Ph.D.
From the Center for Developmental Epidemiology, Duke University Medical Center, Durham, N.C.; the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; and the University of North Carolina at Chapel Hill.

Notes

Address correspondence to Dr. Copeland ([email protected]).

Funding Information

Dr. Shanahan has received grant support from NIMH (MH094605 and MH058144). Dr. Angold has received support from NIMH and the National Institute on Drug Abuse. Dr. Costello has received NIH funding as well as data collection and salary support from 1993 to present. The research presented here was supported by NIMH (MH080230, MH63970, MH63671, MH48085, MH075766), the National Institute on Drug Abuse (DA/MH11301, DA011301, DA016977, DA011301), NARSAD (early career award to Dr. Copeland), and the William T. Grant Foundation.
The authors report no financial relationships with commercial interests.
Supplementary Material

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share